Search results
Results From The WOW.Com Content Network
Gemcitabine is in the nucleoside analog family of medication. [3] It works by blocking the creation of new DNA, which results in cell death. [3] Gemcitabine was patented in 1983 and was approved for medical use in 1995. [7] Generic versions were introduced in Europe in 2009 and in the US in 2010. [8] [9] It is on the WHO Model List of Essential ...
Unnatural Selection (or stylized as, "unnatural selection") is a 2019 American documentary television series.It presents an overview of genetic engineering, particularly the DNA-editing technology of CRISPR, from the perspective of scientists, corporations and biohackers working from their home.
Azacitidine is a chemical analogue of the nucleoside cytidine, which is present in DNA and RNA.It is thought to have antineoplastic activity via two mechanisms – at low doses, by inhibiting of DNA methyltransferase, causing hypomethylation of DNA, [16] and at high doses, by its direct cytotoxicity to abnormal hematopoietic cells in the bone marrow through its incorporation into DNA and RNA ...
ReGenesis is a Canadian science-fiction television series produced by The Movie Network and Movie Central in conjunction with Shaftesbury Films.The series, which ran for four seasons from 2004 to 2008, revolves around the scientists of NorBAC (North American Biotechnology Advisory Commission), a fictional organization with a lab based in the city of Toronto.
James Bell is a Silicon Valley billionaire who dreams of building a hospital with ultimate cutting-edge technology to treat rare and incurable diseases. He partners with a maverick surgeon, Dr. Walter Wallace, who leads the effort in clearing out the bureaucracy of medicine, and focus on forward thinking, advancing technology, and saving lives—at no cost to the patient.
Partial shot from the opening sequence, showing Ben Murphy as Sam Casey and the countdown digital watch that served as his DNA stabilizer. Gemini Man is an American action-adventure drama series that aired on NBC in 1976.
Gene knock-in originated as a slight modification of the original knockout technique developed by Martin Evans, Oliver Smithies, and Mario Capecchi.Traditionally, knock-in techniques have relied on homologous recombination to drive targeted gene replacement, although other methods using a transposon-mediated system to insert the target gene have been developed. [3]
In genetic engineering, a gene cassette is a manipulable fragment of DNA carrying, and capable of expressing, one or more genes of interest between one or more sets of restriction sites. It can be transferred from one DNA sequence (usually on a vector ) to another by 'cutting' the fragment out using restriction enzymes and 'pasting' it back ...